Doç. Dr. Birol Ocak

Long-Term Survival of Cancer Patients Following COVID-19 Infection: Prognostic Value of Inflammatory Indices and Vaccination Status

Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2026

DOI 10.32708/uutfd.1898579 Texte intégral en libre accèsSource : ORCID

Predicting the Unpredictable: Prognostic Role of Systemic Inflammatory Indices and Tumor Biology of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Cancer—Insights from a Systematic Review and Real-World Experience

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15041484 PMID 41753172 Texte intégral en libre accèsSource : ORCID

Optimizing Patient Selection for Bevacizumab Plus Irinotecan in Recurrent High Grade Glioma: Superiority of the Neutrophil-to-Lymphocyte Ratio Over Other Systemic Inflammation Indices

Eurasian Journal of Medical Investigation, 2026

DOI 10.14744/ejmi.263037 Source : OpenAlex

Prognostic Value of Albumin-to-CEA Ratio in Metastatic Colorectal Cancer: A Retrospective Study

Biomedicines, 2026

DOI 10.3390/biomedicines14030579 PMID 41898226 Texte intégral en libre accèsSource : Europe PMC

Clinicopathological Factors Associated with Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer: A Single-Center Retrospective Study

Journal of Bursa Faculty of Medicine, 2026

DOI 10.61678/bursamed.2045961 Texte intégral en libre accèsSource : ORCID

Beyond conventional staging: prognostic significance of systemic inflammatory indices at diagnosis in malignant peripheral nerve sheath tumors

Turkish Journal of Clinics and Laboratory, 2026

DOI 10.18663/tjcl.1860402 Texte intégral en libre accèsSource : ORCID

Integrating Tumor Biology and Host Factors in mCRPC: The Prognostic Value of ‘Time to Castration Resistance’, Systemic Inflammation, and Comorbidity Burden in Patients Treated with Enzalutamide

Diagnostics, 2026

DOI 10.3390/diagnostics16060950 PMID 41897683 Texte intégral en libre accèsSource : ORCID

Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study

Cancer Investigation, 2025

DOI 10.1080/07357907.2025.2595536 PMID 41347635 1 citation (Europe PMC) Source : OpenAlex

Prognostic Value of Histological Subtypes and Clinical Factors in Non-Endemic Nasopharyngeal Carcinoma: A Retrospective Cohort Study

Medicina (Kaunas, Lithuania), 2025

DOI 10.3390/medicina61122207 PMID 41470209 1 citation (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

Managing Bone Metastases with Denosumab: Real-World Data and Critical Monitoring Points in Breast, Lung, and Prostate Cancers

Medicina, 2025

DOI 10.3390/medicina61091637 PMID 41011028 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast

The Oncologist, 2025

DOI 10.1093/oncolo/oyaf171 PMID 40588422 Texte intégral en libre accèsSource : ORCID

Evaluation of complementary and alternative medicine use in cancer patients: A survey study in Turkey

Advances in Integrative Medicine, 2025

DOI 10.1016/j.aimed.2025.01.003 Source : ORCID

Baş-Boyun Kanserlerinde Tek Merkez Setüksimab Deneyimi

Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2025

DOI 10.32708/uutfd.1510864 Texte intégral en libre accèsSource : ORCID

Role of pelvimetry in predicting surgical outcomes and morbidity in rectal cancer surgery: A retrospective analysis

World Journal of Gastrointestinal Surgery, 2025

DOI 10.4240/wjgs.v17.i4.104726 PMID 40291864 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

HER2-Duşuk Ekspresyonunun, Neoadjuvan Kemoterapi Alan HR-Pozitif / HER2-Negatif Meme Kanseri Hastalarında Patolojik Yanıta ve Sağkalıma Etkisi

DergiPark (Istanbul University), 2025

Source : OpenAlex

HER2-Low Expression Predicts Improved Pathologic Response but not Disease-Free Survival in HR-Positive/HER2-Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

DOAJ (DOAJ: Directory of Open Access Journals), 2025

Source : OpenAlex

Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?

Current Oncology, 2024

DOI 10.3390/curroncol31090384 PMID 39330012 Texte intégral en libre accèsSource : OpenAlex

Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey

Journal of Clinical Medicine, 2024

DOI 10.3390/jcm13206216 PMID 39458166 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Isolated Bilateral Adrenal Metastasis in Castration-Resistant Prostate Cancer: A Case Report and Literature Review

Cureus, 2024

DOI 10.7759/cureus.75985 PMID 39834965 Texte intégral en libre accèsSource : OpenAlex

PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

Journal of Geriatric Oncology, 2023

DOI 10.1016/j.jgo.2023.101604 PMID 37683369 10 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study

Journal of Cancer Research and Clinical Oncology, 2023

DOI 10.1007/s00432-023-04766-3 PMID 37067546 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Prognostic factors in atypical carcinoid tumors

The European Research Journal, 2023

DOI 10.18621/eurj.1345267 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID

Early thrombocytopenia predicts longer time-to-treatment discontinuation in trastuzumab emtansine treatment

Oncology Letters, 2023

DOI 10.3892/ol.2023.14110 PMID 37927419 8 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Evaluation of the Frequency of Sleep Disorders, Depression and Anxiety in Patients with Early-Stage Breast Cancer: Cross-Sectional Study

Turkiye Klinikleri Journal of Medical Sciences, 2023

DOI 10.5336/medsci.2022-94294 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer

Breast Care, 2023

DOI 10.1159/000526732 PMID 36876171 7 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.

Journal of Clinical Oncology, 2022

DOI 10.1200/jco.2022.40.16_suppl.e23542 2 citations (OpenAlex) Source : OpenAlex

Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.

Bursa Uludag University - AVESIS, 2022

Source : OpenAlex

Hyperprogression and hypercalcemia after nivolumab treatment in three cases with renal cell carcinoma

Journal of Oncology Pharmacy Practice, 2022

DOI 10.1177/10781552221077418 PMID 35188841 2 citations (Europe PMC) Source : ORCID

Metastatik Yumuşak Doku Sarkomlarında Trabektedin Kullanımının Retrospektif Değerlendirilmesi: Tek Merkez Deneyimi

Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2022

DOI 10.32708/uutfd.1066422 Texte intégral en libre accèsSource : ORCID

Metastatik Endometrioid Endometrial Karsinom Hastalarında Tedavi Seçeneklerinin Sağkalım Üzerine Etkisi

Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2022

DOI 10.32708/uutfd.1028896 Texte intégral en libre accèsSource : ORCID

Radiotherapy could increase the efficacy of immunotherapy in non-small cell lung cancer

Turkish Journal of Internal Medicine, 2022

DOI 10.46310/tjim.1076459 2 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

Chemotherapy plus radiotherapy vs. radiotherapy alone in high-risk endometrioid endometrial carcinoma

European Review for Medical and Pharmacological Sciences, 2022

DOI 10.26355/eurrev_202212_30570 PMID 36524515 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

Platin-based chemotherapy does not improve survival in patients with non-metastatic resected typical carcinoid tumors

Molecular and Clinical Oncology, 2022

DOI 10.3892/mco.2022.2579 PMID 36157316 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

Onkolojik Aciller

Akademisyen Kitabevi eBooks, 2021

DOI 10.37609/akya.352 Source : ORCID

Olgularla Onkolojik Aciller

Akademisyen Kitabevi eBooks, 2021

DOI 10.37609/akya.168 Source : OpenAlex

The impact of Ki-67 index, squamous differentiation and several clinicopathologic parameters on the recurrence of low and intermediate-risk endometrial cancer

Bosnian Journal of Basic Medical Sciences, 2021

DOI 10.17305/bjbms.2020.5437 PMID 33714260 10 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: A single-center retrospective real-world data

Bosnian Journal of Basic Medical Sciences, 2021

DOI 10.17305/bjbms.2020.5329 PMID 33596402 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Why do some patients with stage 1A and 1B endometrial endometrioid carcinoma experience recurrence? A retrospective study in search of prognostic factors

Ginekologia polska, 2021

DOI 10.5603/gp.a2021.0093 PMID 34105738 4 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy

Scientific Reports, 2021

DOI 10.1038/s41598-021-94184-7 PMID 34282214 125 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Clinical and Laboratory Outcomes of the Solid Cancer Patients Reinfected with SARS-CoV-2

Future Oncology, 2021

DOI 10.2217/fon-2021-0621 PMID 34825831 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

The Ki-67 index and neutrophile-lymphocyte ratio are prognostic factors in patients with low-risk endometrial cancer

European Journal of Gynaecological Oncology, 2021

DOI 10.31083/j.ejgo4204117 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

The Importance of Platinum Sensitivity in Metastatic Malignant Pleural Mesothelioma Patients

Eurasian Journal of Medical Investigation, 2021

DOI 10.14744/ejmi.2020.39466 1 citation (OpenAlex) Source : OpenAlex

1568P Clinical and laboratory outcomes of solid cancer patients reinfected with SARS-CoV-2

Annals of Oncology, 2021

DOI 10.1016/j.annonc.2021.08.1561 Texte intégral en libre accèsSource : OpenAlex

KANSER HASTALARININ ORAL KEMOTERAPİ İLAÇLARINA UYUMUNUN DEĞERLENDİRİLMESİ

Bursa Uludag University - AVESIS, 2021

Source : OpenAlex

METASTATİK MALİGN MELANOMDA ANTİ PD1 TEK MERKEZ DENEYİMİ

Bursa Uludag University - AVESIS, 2020

Source : OpenAlex

The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans

Bosnian Journal of Basic Medical Sciences, 2020

DOI 10.17305/bjbms.2020.5088 PMID 33091330 8 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Malign Peritoneal Mezotelyoma Hastalarının Retrospektif Değerlendirilmesi

Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2020

DOI 10.32708/uutfd.696160 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID

Erken Evre Otozomal Dominant Polikistik Bo brek Hastalıg ında FGF23, I nflamasyon ve Demir Metabolizması

Hitit University Institutional Repository, 2020

DOI 10.20515/otd 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Malign Plevral Mezotelyoma

2020

1 citation (OpenAlex) Source : OpenAlex

Tolvaptan in the Treatment of Syndrome of Inappropriate Anti-Diuretic Hormone in Cancer Patients

Eurasian Journal of Medical Investigation, 2020

DOI 10.14744/ejmi.2020.27878 Source : OpenAlex